Four varieties of diabetes mellitus in acute myocardial infarction

Goran Pante Koracevic; Slobodan  Obradović; Tomislav    Kostić; Milan  Pavlović; Marija  Kutlešić; Milovan  Stojanović; Sladjana  Vasiljević; Maja  Koraćević

doi:10.2298/VSP160822188K

Goran Pante Koracevic Department for cardiovascular Diseases, Clinical Center Nis, and Medical Faculty, University of Nis
Slobodan Obradović Military Medical Academy, Clinic of Internal Emergency Medicine, Belgrade, Serbia; University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
Tomislav Kostić Clinical Center Niš, Department for Cardiovascular Diseases, Obstetrics and Gynecology Clinic, Niš, Serbia
Milan Pavlović Clinical Center Niš, Department for Cardiovascular Diseases, Obstetrics and Gynecology Clinic, Niš, Serbia
Marija Kutlešić Clinical Center Niš, Center of Anesthesiology, Niš, Serbia
Milovan Stojanović Institute for Treatment and Rehabilitation Niška Banja, Niška Banja, Serbia
Sladjana Vasiljević Mother and Child Health Care Institute „Dr Vukan Čupić“, Department of Anesthesiology and Intensive Care, Belgrade, Serbia
Maja Koraćević University of Niš, Faculty of Medicine, Innovation Center, Niš, Serbia

DOI: https://doi.org/10.2298/VSP160822188K

Keywords: blood glucose, cardiovascular diseases, diabetes millitus, glucose tolerance test, ; hemoglobin a, glucosylated, myocardial infarction, risk assessment

References

REFERENCES

Aggarwal B, Shah GK, Randhawa M, Ellis SG, Lincoff AM, Menon V. Utility of glycated hemoglobin for assessment of glucose metabolism in patients with st-segment elevation myocardial infarction. Am J Cardiol 2016; 117(5): 749–53.

Bauters C, Lemesle G, de Groote P, Lamblin N. A systematic re-view and meta-regression of temporal trends in the excess mortality associated with diabetes mellitus after myocardial in-farction. Int J Cardiol 2016; 217: 109–21.

Madsbad S. Impact of postprandial glucose control on diabetes-related complications: How is the evidence evolving? J Diabetes Complications 2016; 30(2): 374–85.

Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Methods. Can J Diabetes 2013; 37(Suppl 1): S1–212.

Patel PA, Cubbon RM, Sapsford RJ, Gillott RG, Grant PJ, Witte KK, et al. An evaluation of 20 year survival in patients with diabetes mellitus and acute myocardial infarction. Int J Cardiol 2016; 203: 141–4.

Witt DM, Clark NP, Kaatz S, Schnurr T, Ansell JE. Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism. J Thromb Thrombolysis 2016; 41(1): 187–205.

Wei CC, Shyu KG, Cheng JJ, Lo HM, Chiu CZ. Diabetes and Adverse Cardiovascular Outcomes in Patients with Acute Co-ronary Syndrome - Data from Taiwan's Acute Coronary Syn-drome Full Spectrum Data Registry. Acta Cardiol Sin 2016; 32(1): 31–8.

Mazurek M, Kowalczyk J, Lenarczyk R, Zielinska T, Sedkowska A, Pruszkowska-Skrzep P, et al. The prognostic value of different glucose abnormalities in patients with acute myocardial infarc-tion treated invasively. Cardiovasc Diabetol 2012; 11: 78.

Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I. Is diabetes a coronary risk equivalent? Systematic review and meta-analysis. Diabet Med 2009; 26(2): 142–8.

Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyorala K, Simoons M, et al. The prevalence of abnormal glucose regulation in pa-tients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004; 25(21): 1880–90.

Kuhl J, Jörneskog G, Wemminger M, Bengtsson M, Lundman P, Kalani M. Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemia. Cardiovasc Diabetol 2015; 14: 120.

Usami M, Sakata Y, Nakatani D, Suna S, Matsumoto S, Hara M, et al. Clinical impact of acute hyperglycemia on development of diabetes mellitus in non-diabetic patients with acute myo-cardial infarction. J Cardiol 2014; 63(4): 274–80.

Mozaffarian D, Marfisi R, Levantesi G, Silletta MG, Tavazzi L, Tognoni G, et al. Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors. Lancet 2007; 370(9588): 667–75.

Park CS, Chung WB, Choi YS, Kim PJ, Lee JM, Baek K, et al. Acute Myocardial Infarction Is a Risk Factor for New Onset Diabetes in Patients with Coronary Artery Disease. PLoS One 2015; 10(8): e0136354.

Tavares CA, Wajchjenberg BL, Rochitte C, Lerario AC. Screening for asymptomatic coronary artery disease in patients with type 2 diabetes mellitus. Arch Endocrinol Metab 2016; 60(2): 143–51.

Ishihara M. Acute hyperglycemia in patients with acute myo-cardial infarction. Circ J 2012; 76(3): 563–71.

Koracevic GP. Proposal of a new approach to study and categor-ize stress hyperglycemia in acute myocardial infarction. J Emerg Med 2016; 51(1): 31–6.

Gomez-Arbelaez D, Sánchez-Vallejo G, Perez M, Garcia RG, Ar-guello JF, Peñaherrera E, et al. Hyperglycaemia is associated with worse outcomes in Latin-American individuals with acute myocardial infarction. Clin Investig Arterioscler 2016; 28(1): 9–18. (Spanish)

Rousan TA, Pappy RM, Chen AY, Roe MT, Saucedo JF. Impact of diabetes mellitus on clinical characteristics, management, and in-hospital outcomes in patients with acute myocardial infarction (from the ncdr). Am J Cardiol 2014; 114(8): 1136–44.

Colombo MG, Meisinger C, Amann U, Heier M, von Scheidt W, Kuch B, et al. Association of obesity and long-term mortality in patients with acute myocardial infarction with and without di-abetes mellitus: results from the MONICA/KORA myocardial infarction registry. Cardiovasc Diabetol 2015; 14(1): 24.

Bundhun PK, Li N, Chen M. Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic pa-tients after percutaneous coronary intervention: a systematic review and meta-analysis. Cardiovasc Diabetol 2015; 14(1): 135.

Arnold SV, Spertus JA, Lipska KJ, Tang F, Goyal A, McGuire DK, et al. Association between diabetes mellitus and angina after acute myocardial infarction: analysis of the TRIUMPH prospective cohort study. Eur J Prev Cardiol 2015; 22(6): 779–87.

Liu H, Zhou C, Yu J, Jiang Q, Hu D. Reduced kidney function in acute coronary syndrome patients with undiagnosed di-abetes or pre-diabetes. Nephrology (Carlton) 2013; 18(4): 263–8.

Koracevic GP, Petrovic S, Damjanovic M, Stanojlovic T. Association of stress hyperglycemia and atrial fibrillation in myocardial in-farction. Wien Klin Wochenschr 2008; 120(13–14): 409–13.

Vergès B, Avignon A, Bonnet F, Catargi B, Cattan S, Cosson E, et al. Diabetes and cardiovascular Disease study group of the So-ciété francophone du diabète (SFD), in collaboration with the Société française de cardiologie (SFC). Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome. Di-abetes Metab 2012; 38(2): 113–27.

Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, et al. Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC); Euro-pean Association for the Study of Diabetes (EASD). ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseas-es developed in collaboration with the EASD - summary. Diab Vasc Dis Res 2014; 11(3): 133–73.

Le VT , Knight S, Anderson JL, Lappé DL, May HT, Horne BD, et al. Undiagnosed diabetes at the time of acute myocardial in-farction is frequent and associated with poor cardiovascular outcomes. Circulation 2015; 132: A15117.

American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2010; 33(Suppl 1): S62–9.

American Diabetes Association. Standards of medical care in di-abetes. Diabetes Care 2016; 39(Suppl 1): S1-S106.

Koracevic GP. Using a single cut-off for stress hyperglycemia in myocardial infarction decreases its prognostic value particular-ly in diabetes. Am J Emerg Med 2014; 32(1): 103–4.

Koraćević G, Vasiljević S, Veličković-Radovanović R, Sakac D, Obradović S, Damjanović M, et al. Stress hyperglycemia in acute myocardial infarction. Vojnosanit Pregl 2014; 71(9): 858–69.

Koracevic GP. Various admission glucose cut-offs for prognosti-cation and for therapeutic threshold in acute myocardial in-farction. Am J Emerg Med 2015; 33(1): 108–9.

Henareh L, Agewall S. 2-h postchallenge plasma glucose predicts cardiovascular events in patients with myocardial infarction without known diabetes mellitus. Cardiovasc Diabetol 2012; 11: 93.

George A, Bhatia RT, Buchanan GL, Whiteside A, Moisey RS, Beer SF, et al. Impaired glucose tolerance or newly diagnosed diabetes mellitus diagnosed during admission adversely affects prognosis after myocardial infarction: an observational study. PLoS One 2015; 10(11): e0142045.

Naito R, Miyauchi K, Ogita M, Kasai T, Kawaguchi Y, Tsuboi S, et al. Impact of admission glycemia and glycosylated hemoglobin A1c on long-term clinical outcomes of non-diabetic patients with acute coronary syndrome. J Cardiol 2014; 63(2): 106–11.

Pararajasingam G, Høfsten DE, Løgstrup BB, Egstrup M, Henriksen FL, Hangaard J, et al. Newly detected abnormal glucose regulation and long-term prognosis after acute myocardial infarction: Comparison of an oral glucose tolerance test and glycosylated haemoglobin A1c. Int J Cardiol 2016; 214: 310–5.

Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metare-gression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999; 22(2): 233–40.

American Diabetes Association. Standards of medical care in di-abetes - 2012. Diabetes Care 2012; 35(Suppl 1): S11–63.

Abdullatef WK, Al-Aqeedi RF, Dabdoob W, Hajar HA, Bener A, Gehani AA. Prevalence of unrecognized diabetes mellitus in patients admitted with acute coronary syndrome. Angiology 2013; 64(1): 26–30.

Senthinathan A, Kelly V, Dzingina M, Jones D, Baker M, Longson D. Hyperglycaemia in acute coronary syndromes: summary of NICE guidance. BMJ 2011; 343: d6646.

Ritsinger V, Tanoglidi E, Malmberg K, Näsman P, Rydén L, Tenerz Å, et al. Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort. Diab Vasc Dis Res 2015; 12(1): 23–32.

Ye Y, Xie H, Zhao X, Zhang S. The oral glucose tolerance test for the diagnosis of diabetes mellitus in patients during acute coronary syndrome hospitalization: a meta-analysis of diagnos-tic test accuracy. Cardiovasc Diabetol 2012; 11(1): 155.

Bronisz A, Kozinski M, Magielski P, Fabiszak T, Gierach J, Swiatkiewicz I, et al. Value of oral glucose tolerance test in the acute phase of myocardial infarction. Cardiovasc Diabetol 2011; 10(1): 21.

American Diabetes Association (ADA). Standards of medical care in diabetes Diabetes Care 2015; 38(Suppl 1): S1–S90.

de la Hera JM, García-Ruiz JM, Martínez-Camblor P, Martín M, Tellería AL, Corros C, et al. Real incidence of diabetes mellitus in a coronary disease population. Am J Cardiol 2013; 111(3): 333–8.

Colomo N, Linares F, Rubio-Martín E, Moreno MJ, de Mora M, García AM, et al. Stress hyperglycaemia in hospitalized patients with coronary artery disease and type 2 diabetes risk. Eur J Clin Investig 2013; 43(10): 1060–8.

Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Arnesen H, et al. Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients. Cardiovasc Diabetol 2009; 8: 6.

Gierach J, Gierach M, Świątkiewicz I, Woźnicki M, Grześk G, Su-kiennik A, et al. Admission glucose and left ventricular systolic function in non-diabetic patients with acute myocardial infarction. Heart Vessels 2016; 31(3): 298–307.

Bronisz A, Kozinski M, Magielski P, Fabiszak T, Bronisz M, Swiatkiewicz I, et al. Stress hyperglycaemia in patients with first myocardial infarction. Int J Clinl Pract 2012; 66(6): 592–601.

Gitt A, Bramlage P, Towae F, Papp A, Deeg E, Senges J, et al. Newly diagnosed diabetes and prediabetes in patients after acute myocardial infarction predicts adverse outcomes during a three-year follow-up: results of the sweetheart registry. JACC 2013; 61(10): E176.

Task Force Members. Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collabora-tion with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardi-ology (ESC) and developed in collaboration with the Euro-pean Association for the Study of Diabetes (EASD). Eur Heart J 2013; 34(39): 3035–87.

Task Force of the SEC for the ESC Guidelines on Diabetes, Prediabetes and Cardiovascular Disease; Expert Reviewers for the ESC Guidelines on Diabetes, Prediabetes And Cardiovas-cular Disease; Guideliness Committee of the SEC. Comments on the ESC guidelines on diabetes, prediabetes, and cardiovas-cular diseases developed in collaboration with the european society for the study of diabetes. Rev Esp Cardiol (Engl Ed) 2014; 67(2): 87–93.

Monteiro CM, Oliveira L, Izar MC, Helfenstein T, Santos AO, Fischer SM, et al. Early glucometabolic profile in patients with acute coronary syndromes and metabolic syndrome. Arq Bras Cardiol 2009; 92(2): 89–99. (English, Portuguese, Spanish)

Kowalczyk J, Mazurek M, Zielinska T, Lenarczyk R, Sedkowska A, Swiatkowski A, et al. Prognostic significance of HbA1c in pa-tients with AMI treated invasively and newly detected glucose abnormalities. Eur J Prev Cardiol 2015; 22(6): 798–806.

Snir A, Dabin B, Hyun K, Yamen E, Ryan M, Aliprandi-Costa B, et al. Glycosylated haemoglobin assessment in diabetic patients with acute coronary syndromes. Intern Med J 2016; 46(5): 574–82.

Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and the European Society of Cardiology. 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Press 2014; 23(1): 3–16.

Sternlicht H, Bakris GL. Hydrochlorothiazide as the Diuretic of Choice for Hypertension: Time to Kick the Habit. J Am Coll Cardiol 2016; 67(4): 390–1

Navarese EP, Buffon A, Andreotti F, Kozinski M, Welton N, Fabiszak T, et al. Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus. Am J Cardiol 2013; 111(8): 1123–30.